Pacira BioSciences, Inc.
PCRX
$23.00
-$0.18-0.78%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.47% | -9.90% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.47% | -9.90% | |||
| Cost of Revenue | 21.29% | -20.49% | |||
| Gross Profit | 5.16% | -6.69% | |||
| SG&A Expenses | -2.27% | -7.54% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.51% | -13.27% | |||
| Operating Income | 156.45% | 300.30% | |||
| Income Before Tax | -48.88% | 775.31% | |||
| Income Tax Expenses | -200.77% | 295.31% | |||
| Earnings from Continuing Operations | 59.57% | 78.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 59.57% | 78.13% | |||
| EBIT | 156.45% | 300.30% | |||
| EBITDA | 30.29% | 5.80% | |||
| EPS Basic | 63.52% | 87.27% | |||
| Normalized Basic EPS | 282.62% | 170.71% | |||
| EPS Diluted | 68.43% | 81.82% | |||
| Normalized Diluted EPS | 278.37% | 170.87% | |||
| Average Basic Shares Outstanding | -2.47% | -4.78% | |||
| Average Diluted Shares Outstanding | -1.49% | -4.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||